Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis

Lancet Infect Dis. 2021 Jun;21(6):766-767. doi: 10.1016/S1473-3099(21)00060-8. Epub 2021 Mar 1.

Authors

Nitipong Permpalung¹, Johan Maertens², Kieren A Marr³

Affiliations

¹ Departments of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: npermpa1@jhmi.edu.
² Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
³ Departments of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Consensus
Humans
Invasive Pulmonary Aspergillosis* / diagnosis
Invasive Pulmonary Aspergillosis* / drug therapy
Pulmonary Aspergillosis* / diagnosis
Pulmonary Aspergillosis* / drug therapy
SARS-CoV-2